Table: OncoTherapy Science -2019/20 parent results

OncoTherapy Science

08/05/2020 09:00

May 8 (Reuters)- 
          OncoTherapy Science Inc 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          114 mln         205 mln                               
               (-44.3 pct)     (-0.3 pct)                              
  Operating     loss 1.82       loss 2.18                              
  Recurring     loss 1.79       loss 2.17                              
  Net           loss 1.98       loss 3.40                              
  EPS        loss 12.13 yen  loss 23.05 yen                            
  Ann Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T